{{refimprove|time=2011-06-06T03:10:08+00:00}}
{{medical}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 459983915
| IUPAC_name = (5′α)-2-Bromo-12′-hydroxy-5′-(2-methylpropyl)-3′,6′,18-trioxo-2′-(propan-2-yl)ergotaman
| image = Bromocriptine.svg
| image2 = Bromocriptine ball-and-stick.png
<!--Clinical data-->
| tradename = Originally Parlodel, subsequently many<ref name=brands/>
| Drugs.com = {{drugs.com|monograph|parlodel}},{{drugs.com|international|brotin}}
| MedlinePlus = a682079
| pregnancy_AU = A
| pregnancy_US = B
| legal_AU = S4
| legal_CA = Rx-only
| legal_US = Rx-only
| legal_UK = POM
| routes_of_administration = oral, vaginal, intravenous 
<!--Pharmacokinetic data-->
| bioavailability = 28% of oral dose absorbed
| metabolism = Extensively liver-mediated
| elimination_half-life = 12-14 hours
| excretion = 85% bile (faeces), 2.5-5.5% urine
<!--Identifiers-->
| synonyms = 2-Bromoergocriptine
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 25614-03-3
| ATC_prefix = G02
| ATC_suffix = CB01
| ATC_supplemental = {{ATC|N04|BC01}}
| PubChem = 31101
| IUPHAR_ligand = 35
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01200
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 28858
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3A64E3G5ZO
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03165
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3181
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 493
<!--Chemical data-->
| C=32 | H=40 | Br=1 | N=5 | O=5
| molecular_weight = 654.595 g/mol
| smiles = BrC1=C(C[C@H]2N(C)C3)C4=C(C=CC=C4C2=C[C@H]3C(N[C@]5(C(C)C)O[C@@]6(N([C@@H](CC(C)C)C(N7CCC[C@H]76)=O)C5=O)O)=O)N1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OZVBMTJYIDMWIL-AYFBDAFISA-N
}}
'''溴隱亭'''（{{lang-en|'''Bromocriptine'''}}）是一種[[多巴胺受體激動劑|多巴胺受體激動劑]]，屬於ergoline的衍生物。可用於控制因腦部問題而產生乳汁的患者<ref name=appledaily20110525>{{cite news |url=http://hk.apple.nextmedia.com/template/apple/art_main.php?iss_id=20110525&sec_id=15335&subsec_id=15336&art_id=15283947 |title=初為人父　乳房分泌乳汁 |publisher=[[蘋果日報_(香港)|蘋果日報]] |date=2011-05-25 |language=zh-hant}}</ref>。

==商品==
*[[保乳調錠|保乳調錠]]

== 參考資料 ==
{{reflist}}

{{抗帕金森病}}
{{Aphrodisiacs}}
{{Hallucinogens}}

[[Category:多巴胺激動劑|Category:多巴胺激動劑]]
[[Category:有機溴化合物|Category:有機溴化合物]]